住友ファーマの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2023/01/10 | 934 | 936 | 908 | 909 | -26 | -2.8% | 1,279,300 |
2023/01/06 | 938 | 947 | 934 | 935 | -6 | -0.6% | 944,100 |
2023/01/05 | 967 | 969 | 938 | 941 | -29 | -3% | 1,266,100 |
2023/01/04 | 1,001 | 1,001 | 970 | 970 | -29 | -2.9% | 1,140,200 |
2022/12/30 | 1,012 | 1,014 | 997 | 999 | -12 | -1.2% | 813,400 |
2022/12/29 | 999 | 1,011 | 993 | 1,011 | +10 | +1% | 738,000 |
2022/12/28 | 995 | 1,002 | 991 | 1,001 | +3 | +0.3% | 785,900 |
2022/12/27 | 1,004 | 1,008 | 997 | 998 | -3 | -0.3% | 557,100 |
2022/12/26 | 1,004 | 1,007 | 999 | 1,001 | -1 | -0.1% | 467,600 |
2022/12/23 | 1,001 | 1,004 | 994 | 1,002 | -3 | -0.3% | 751,900 |
2022/12/22 | 1,010 | 1,010 | 1,001 | 1,005 | -1 | -0.1% | 538,900 |
2022/12/21 | 1,006 | 1,011 | 1,000 | 1,006 | -3 | -0.3% | 641,300 |
2022/12/20 | 1,025 | 1,031 | 1,001 | 1,009 | -14 | -1.4% | 791,900 |
2022/12/19 | 1,024 | 1,026 | 1,015 | 1,023 | -7 | -0.7% | 663,000 |
2022/12/16 | 1,036 | 1,038 | 1,027 | 1,030 | -24 | -2.3% | 877,700 |
2022/12/15 | 1,053 | 1,062 | 1,049 | 1,054 | +1 | +0.1% | 515,400 |
2022/12/14 | 1,047 | 1,056 | 1,043 | 1,053 | +10 | +1% | 581,100 |
2022/12/13 | 1,054 | 1,055 | 1,037 | 1,043 | -6 | -0.6% | 857,400 |
2022/12/12 | 1,058 | 1,059 | 1,043 | 1,049 | -12 | -1.1% | 819,300 |
2022/12/09 | 1,044 | 1,062 | 1,044 | 1,061 | +13 | +1.2% | 1,040,000 |
2022/12/08 | 1,052 | 1,058 | 1,037 | 1,048 | -1 | -0.1% | 625,400 |
2022/12/07 | 1,039 | 1,050 | 1,034 | 1,049 | -1 | -0.1% | 576,600 |
2022/12/06 | 1,039 | 1,062 | 1,033 | 1,050 | +7 | +0.7% | 762,900 |
2022/12/05 | 1,057 | 1,057 | 1,035 | 1,043 | -8 | -0.8% | 870,500 |
2022/12/02 | 1,056 | 1,063 | 1,047 | 1,051 | -13 | -1.2% | 891,200 |
2022/12/01 | 1,084 | 1,084 | 1,060 | 1,064 | -3 | -0.3% | 720,300 |
2022/11/30 | 1,067 | 1,073 | 1,057 | 1,067 | -1 | -0.1% | 1,201,500 |
2022/11/29 | 1,079 | 1,079 | 1,061 | 1,068 | -9 | -0.8% | 627,900 |
2022/11/28 | 1,096 | 1,099 | 1,073 | 1,077 | -19 | -1.7% | 778,800 |
2022/11/25 | 1,085 | 1,098 | 1,081 | 1,096 | +13 | +1.2% | 618,300 |
2022/11/24 | 1,084 | 1,090 | 1,076 | 1,083 | +3 | +0.3% | 772,100 |
2022/11/22 | 1,078 | 1,089 | 1,070 | 1,080 | +7 | +0.7% | 865,400 |
2022/11/21 | 1,070 | 1,075 | 1,064 | 1,073 | +11 | +1% | 781,100 |
2022/11/18 | 1,070 | 1,075 | 1,061 | 1,062 | -3 | -0.3% | 1,042,500 |
2022/11/17 | 1,061 | 1,073 | 1,061 | 1,065 | +2 | +0.2% | 956,200 |
2022/11/16 | 1,055 | 1,080 | 1,046 | 1,063 | +7 | +0.7% | 1,166,600 |
2022/11/15 | 1,048 | 1,068 | 1,047 | 1,056 | +7 | +0.7% | 1,268,700 |
2022/11/14 | 1,022 | 1,059 | 1,022 | 1,049 | +21 | +2% | 1,757,300 |
2022/11/11 | 1,028 | 1,030 | 1,014 | 1,028 | +23 | +2.3% | 1,530,500 |
2022/11/10 | 990 | 1,014 | 989 | 1,005 | +11 | +1.1% | 1,291,300 |
2022/11/09 | 1,011 | 1,012 | 991 | 994 | -23 | -2.3% | 1,267,800 |
2022/11/08 | 1,029 | 1,029 | 1,010 | 1,017 | +2 | +0.2% | 1,142,400 |
2022/11/07 | 1,017 | 1,025 | 1,013 | 1,015 | +1 | +0.1% | 887,400 |
2022/11/04 | 998 | 1,016 | 994 | 1,014 | +5 | +0.5% | 1,214,100 |
2022/11/02 | 996 | 1,010 | 988 | 1,009 | +10 | +1% | 1,879,500 |
2022/11/01 | 1,007 | 1,031 | 997 | 999 | -38 | -3.7% | 1,827,100 |
2022/10/31 | 1,030 | 1,039 | 1,026 | 1,037 | +19 | +1.9% | 1,211,800 |
2022/10/28 | 1,011 | 1,027 | 1,011 | 1,018 | +3 | +0.3% | 2,035,800 |
2022/10/27 | 1,043 | 1,043 | 1,013 | 1,015 | -24 | -2.3% | 1,500,400 |
2022/10/26 | 1,029 | 1,048 | 1,027 | 1,039 | +20 | +2% | 1,299,200 |
551~
600
件表示中 / 3675件
類似銘柄と比較する
現在ご覧いただいている「住友ファーマ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
住友ファーマ | 52,900円 | +21.1% | - | 0.00% | 13.14倍 | 1.84倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
ペプチド | 177,100円 | +5.0% | +1.5% | 0.00% | 15.21倍 | 4.05倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
日本新薬 | 336,400円 | +7.9% | +8.9% | 3.69% | 7.19倍 | 0.97倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
科研薬 | 426,900円 | +22.8% | +113.0% | 4.45% | 11.87倍 | 1.06倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
キッセイ薬 | 362,000円 | +14.5% | -2.3% | 2.49% | 13.24倍 | 0.70倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
市場注目の銘柄
チャート関連のコラム